Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle
Abstract Background Cancer cachexia is a life‐threatening metabolic syndrome that causes significant loss of skeletal muscle mass and significantly increases mortality in cancer patients. Currently, there is an urgent need for better understanding of the molecular pathophysiology of this disease so...
Saved in:
Main Authors: | Rachel L. Nosacka (Author), Andrea E. Delitto (Author), Dan Delitto (Author), Rohan Patel (Author), Sarah M. Judge (Author), Jose G. Trevino (Author), Andrew R. Judge (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumour‐derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour‐bearing mice
by: Susan C. Kandarian, et al.
Published: (2018) -
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
by: Daria Neyroud, et al.
Published: (2021) -
Patient‐derived pancreatic tumour organoid implantation establishes novel pre‐cachexia mouse models
by: Merel R. Aberle, et al.
Published: (2023) -
Cancer cachexia impairs neural respiratory drive in hypoxia but not hypercapnia
by: Daryl P. Fields, et al.
Published: (2019) -
Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
by: Jochen Springer, et al.
Published: (2023)